 |
BioWorld-International-2005-04-27
TKT Absorbed For $1.6B As Shire Fattens Pipeline
TKT Absorbed For $1.6B As Shire Fattens Pipeline
In what could be the largest acquisition of 2005 - and certainly the largest so far - Shire Pharmaceuticals Group plc has nabbed Transkaryotic Therapies Inc. in a deal worth $1.6 billion. (BioWorld International)